[Esophago-gastroduodenal involvement in human immunodeficiency virus infection].
Bouchaud
O
O
Service des Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude-Bernard, Paris.
René
E D
ED
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology* / Q000821:virology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000998:Antiviral Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D004067:Digestive System Neoplasms / Q000209:etiology; D004358:Drug Therapy; D004378:Duodenal Diseases / Q000150:complications* / Q000821:virology; D004935:Esophageal Diseases / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D005756:Gastritis / Q000150:complications* / Q000821:virology; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology; D008297:Male; D012514:Sarcoma, Kaposi / Q000209:etiology; D014777:Virus Diseases / Q000150:complications* / Q000188:drug therapy / Q000821:virology
D000998:Antiviral Agents
Atteintes oeso-gastro-duodénales au cours de l'infection par le virus de l'immunodéficience humaine.